@adamfeuerstein 6-month FEV1 data from VX-809 combo ph3 will impress and prove those who were skeptical based on '56 day' data WRONG.avidresearch (@avidresearch) January 2, 2014
@adamfeuerstein AMGN buys UCBSan (@LukatonMateo) January 5, 2014
The Nasdaq and S&P 500 ended at records for the second day in a row.
S&P 500 and Nasdaq at record highs.
Remarkable data was released from Vertex's triple regiment combination trials.
Vertex Pharmaceuticals, FibroGen and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading trading on July 19.